#9450
Strongyloïdes
ratti IgG ELISA
ELISA kit for the diagnosis of human strongyloidosis
Lot 2316S (Expiry date : 31.12.2024)
Production date : 01.05.2023
Results of quality control 3 (after
12 months), date: 25.04.2024
No serum blank (average) : 0.109
Sample |
Absorbances of individual wells after blank reduction |
Average |
% pos. |
No serum blank
|
-0.002 |
-0.002 |
0.007 |
-0.004 |
0.000 |
0 |
Negative control serum
(N° 9450-06) |
0.084 |
0.091 |
0.092 |
0.083 |
0.088 |
4 |
Weak positive serum
(N° 9450-07) |
0.743 |
0.729 |
0.724 |
0.770 |
0.742 |
34 |
Positive control serum
(N° 9450-08) |
2.169 |
2.214 |
2.103 |
2.249 |
2.184 |
100 |
Validation criteria:
|
Criterion |
Measure |
Valid |
Absorbance of positive serum 9450-08 |
> 1.200 |
2.184 |
Yes |
Absorbance of weak positive serum 9450-07, as % of positive
serum |
> 18 % |
34 % |
Yes |
Absorbance of negative serum 9450-06, as % of positive serum |
< 10 % |
4 % |
Yes |
Absorbance of no serum blank |
< 0.350 |
0.109 |
Yes |
Comments:
Good for use.
Bordier Affinity Products SA, Chatanerie 2,
Bâtiment Biokema,
CH-1023 Crissier, Switzerland
Phone: + 41 21 633 31 67. Fax: +
41 21 633 31 78. Email: cb(at)bordier.ch
|